Crossmark

Generation of Mycoplasma hominis gene-targeted mutants by targeting-induced local lesions in genomes (TILLING)

Crossref DOI link: https://doi.org/10.1186/s12864-018-4917-1

Published Online: 2018-07-09

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pereyre, S. http://orcid.org/0000-0003-1757-4206
Bénard, C.

Brès, C.

Le Roy, C.

Mauxion, J. P.

Rideau, F.

Sirand-Pugnet, P.

Henrich, B.

Bébéar, C.
Funding

Funding for this research was provided by:

Conseil Régional d'Aquitaine (20030304002FA, 20040305003FA)

European Union FEDER (2003227)

Investissements d'Avenir (ANR-10-EQPX-16-01)
License Information

Text and Data Mining valid from 2018-07-09
More Information

Article History

Received: 20 April 2018

Accepted: 3 July 2018

First Online: 9 July 2018

Ethics approval and consent to participate

: Not applicable. No human samples and no animals were used.The M. hominis PG21 reference strain was from ATCC (ATCC 23114). The HeLa cells were Human cervical carcinoma cell line HeLa S3 (ATCC CCL2.2).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.